Hoth Therapeutics Inc (HOTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,857 | -2,147 | -8,106 | -6,143 | -4,057 |
| Accounts payable and accrued liabilities | 1 | -39 | -701 | 538 | 331 |
| Other Working Capital | 20 | -91 | -487 | 397 | 104 |
| Other Operating Activity | 520 | 553 | 847 | -168 | -117 |
| Operating Cash Flow | $-3,316 | $-1,724 | $-8,447 | $-5,376 | $-3,739 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,682 | N/A | 11,317 | 11,317 | 8,911 |
| Financing Cash Flow | $3,682 | $N/A | $11,317 | $11,317 | $8,911 |
| Exchange Rate Effect | -4 | -6 | -7 | -542 | -56 |
| Beginning Cash Position | 9,292 | 9,292 | 6,429 | 6,429 | 6,429 |
| End Cash Position | 9,655 | 7,563 | 9,292 | 11,828 | 11,545 |
| Net Cash Flow | $363 | $-1,730 | $2,864 | $5,400 | $5,116 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,316 | -1,724 | -8,447 | -5,376 | -3,739 |
| Free Cash Flow | -3,316 | -1,724 | -8,447 | -5,376 | -3,739 |